Results 201 to 210 of about 64,532 (302)

Influence of patient factors on target plasma volume treated attainment rate during double filtration plasmapheresis in patients with hypertriglyceridemic acute pancreatitis

Therapeutic Apheresis and Dialysis, EarlyView.
Abstract Introduction This study aims to investigate patient factors affecting the rate of plasma volume target attained in hypertriglyceridemic pancreatitis (HTG‐AP) patients undergoing double filtration plasmapheresis (DFPP). Methods A retrospective analysis of 82 HTG‐AP‐interpreted patients from January 2019 to April 2024 compared target plasma ...
Hui Zhang, Chenqiang Zhu, Yunlong Wu
wiley   +1 more source

WCN24-2585 Outcomes of commercial kidney transplantation: single center experience

Kidney International Reports
Ali M. Shendi, Fahad Al Jabir, Mahmoud A. Alshanqiti, Tariq Ali, Dieter C. Broering, Hassan Aleid   +5 more
doaj   +1 more source

BEAT-BK: An Adaptive, Randomized Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney-pancreas Transplantation Recipients (BEAT-BK) Study Protocol. [PDF]

Transplant Direct
Gately R, Dymock M, Sabanayagam D, Campbell SB, Craig JC, Dharnidharka V, Francis A, Gleadle JM, Hajek M, Hamilton S, Howell M, Isbel N, Jaure A, Johnson DW, Kanellis J, Keung K, Kim S, Kok J, Kuypers DR, Larkins N, Lim WH, Mainra R, Marsh JA, Mihala G, Nankivell BJ, Ng S, Pilmore H, Scholes-Roberton N, Snelling T, Teixeira-Pinto A, Valks A, Yong K, Hawley C, Wong G.   +33 more
europepmc   +1 more source

A Cross‐Organ Symphony of Human Immune System Maturation

Organ Medicine, EarlyView.
Zhan‐Li Chen
wiley   +1 more source

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Conditional Survival for Pancreas Graft and Its Associated Factors After Pancreas Transplantation. [PDF]

Ann Gastroenterol Surg
Tomimaru Y, Ito T, Kitamura T, Kenmochi T, Doki Y, Eguchi H.   +5 more
europepmc   +1 more source

Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes, Rishi S. Kotecha, Derek J. Roebuck   +2 more
wiley   +1 more source

Donor after circulatory death in pancreas transplantation: a scoping review of the literature. [PDF]

Front Transplant
Chassot M, Scheen M, Wassmer CH, Compagnon P, Peloso A, Haidar F.   +5 more
europepmc   +1 more source

Clinical Need and Research Investment for Liver Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Liver cancer incidence and mortality rates have been rising in comparison to other common cancers, but research funding has not been commensurate. ABSTRACT Aim This study aims to better understand factors driving the rising burden and costs of primary liver cancer (PLC) in Australia, identify key epidemiological trends, and ascertain investment in PLC ...
Romario Nguyen, Fatema Safri, Ankur Sharma, Jessica Howell, Stuart K. Roberts, Simone I. Strasser, Amany Zekry, Alan Wigg, Leon A. Adams, Michael Wallace, Golo Ahlenstiel, Eleonora Feletto, Karen Canfell, Tracey O'Brien, Jacob George, Liang Qiao   +15 more
wiley   +1 more source

Process Variation in Liver, Kidney, and Pancreas Transplantation: A Multicenter Evaluation From the Consortium for the Holistic Assessment of Risk in Transplant. [PDF]

Transplant Direct
Strauss AT, Caicedo JC, Welsh W, Reed RD, Gordon EJ, Taber D, Ng YH, Ross-Driscoll K, Schold JD, Serper M, Olson A, Harding JL, Adams A, Kirk AD, McElroy LM.   +14 more
europepmc   +1 more source